ES461388A1 - Un procedimiento para la preparacion de un compuesto de pi- rrolidona. - Google Patents

Un procedimiento para la preparacion de un compuesto de pi- rrolidona.

Info

Publication number
ES461388A1
ES461388A1 ES461388A ES461388A ES461388A1 ES 461388 A1 ES461388 A1 ES 461388A1 ES 461388 A ES461388 A ES 461388A ES 461388 A ES461388 A ES 461388A ES 461388 A1 ES461388 A1 ES 461388A1
Authority
ES
Spain
Prior art keywords
phenyl
alkyl
carbon atoms
tetrazol
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461388A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES461388A1 publication Critical patent/ES461388A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES461388A 1976-08-06 1977-08-05 Un procedimiento para la preparacion de un compuesto de pi- rrolidona. Expired ES461388A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
ES461388A1 true ES461388A1 (es) 1978-12-01

Family

ID=24861795

Family Applications (2)

Application Number Title Priority Date Filing Date
ES461388A Expired ES461388A1 (es) 1976-08-06 1977-08-05 Un procedimiento para la preparacion de un compuesto de pi- rrolidona.
ES471349A Expired ES471349A1 (es) 1976-08-06 1978-07-01 Un procedimiento para la preparacion de un compuesto de pi- rrolidona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES471349A Expired ES471349A1 (es) 1976-08-06 1978-07-01 Un procedimiento para la preparacion de un compuesto de pi- rrolidona

Country Status (31)

Country Link
JP (2) JPS5321159A (enExample)
AR (1) AR217080A1 (enExample)
AT (1) AT362887B (enExample)
AU (1) AU508007B2 (enExample)
BE (1) BE857506A (enExample)
BG (1) BG31073A3 (enExample)
CA (1) CA1077948A (enExample)
CH (1) CH624934A5 (enExample)
CS (1) CS221269B2 (enExample)
DD (2) DD136135A5 (enExample)
DE (1) DE2735904A1 (enExample)
DK (1) DK352077A (enExample)
ES (2) ES461388A1 (enExample)
FI (1) FI70009C (enExample)
FR (1) FR2369260A1 (enExample)
GB (2) GB1556569A (enExample)
GR (1) GR68688B (enExample)
HU (1) HU180273B (enExample)
IE (1) IE45505B1 (enExample)
IL (1) IL52615A (enExample)
LU (1) LU77936A1 (enExample)
NL (1) NL7708637A (enExample)
NO (1) NO772752L (enExample)
NZ (1) NZ184806A (enExample)
PH (1) PH17398A (enExample)
PL (2) PL112931B1 (enExample)
PT (1) PT66891B (enExample)
SE (1) SE423813B (enExample)
SU (3) SU703016A3 (enExample)
YU (1) YU192577A (enExample)
ZA (1) ZA774704B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
DE60120007T2 (de) * 2000-01-31 2006-11-16 Pfizer Products Inc., Groton Verwendung von Aktivatoren des Prostaglandinrezeptores 4 zur Behandlung von akuter oder chronischer Niereninsuffizienz
WO2002024647A1 (en) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
PT1339678E (pt) * 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
NZ530885A (en) * 2001-07-23 2007-09-28 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having EP4 agonist as the active ingredient
CA2478653A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
US6573294B1 (en) 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
US7256211B1 (en) * 2003-01-21 2007-08-14 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AR217080A1 (es) 1980-02-29
SU818480A3 (ru) 1981-03-30
CA1077948A (en) 1980-05-20
JPS5555161A (en) 1980-04-22
YU192577A (en) 1983-04-30
AU508007B2 (en) 1980-03-06
GB1556569A (en) 1979-11-28
PH17398A (en) 1984-08-08
IL52615A0 (en) 1977-10-31
JPS5321159A (en) 1978-02-27
NO772752L (no) 1978-02-07
ATA579477A (de) 1980-11-15
CS221269B2 (en) 1983-04-29
JPS5531147B2 (enExample) 1980-08-15
ZA774704B (en) 1978-06-28
BG31073A3 (bg) 1981-10-15
DD143768A5 (de) 1980-09-10
DE2735904A1 (de) 1978-02-09
PL112931B1 (en) 1980-11-29
FI772376A7 (enExample) 1978-02-07
AT362887B (de) 1981-06-25
SE7708642L (sv) 1978-02-07
HU180273B (en) 1983-02-28
FI70009B (fi) 1986-01-31
FR2369260A1 (fr) 1978-05-26
IE45505B1 (en) 1982-09-08
PL200124A1 (pl) 1978-05-22
SU703016A3 (ru) 1979-12-05
AU2751577A (en) 1979-02-08
CH624934A5 (enExample) 1981-08-31
JPS585196B2 (ja) 1983-01-29
DD136135A5 (de) 1979-06-20
NL7708637A (nl) 1978-02-08
GR68688B (enExample) 1982-02-01
SU850000A3 (ru) 1981-07-23
SE423813B (sv) 1982-06-07
NZ184806A (en) 1980-04-28
IL52615A (en) 1981-09-13
PT66891B (en) 1979-01-26
LU77936A1 (enExample) 1978-04-27
DK352077A (da) 1978-02-07
PT66891A (en) 1977-09-01
BE857506A (fr) 1978-02-06
FR2369260B1 (enExample) 1982-02-12
IE45505L (en) 1978-02-06
FI70009C (fi) 1986-09-12
GB1556570A (en) 1979-11-28
ES471349A1 (es) 1979-09-16

Similar Documents

Publication Publication Date Title
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
AR240792A2 (es) Compuesto derivados de 2-(benzoilo substituido) -1,3 -ciclohexanodiona y composicion herbicida que los comprende.
ES481220A1 (es) Un procedimiento para la preparacion de 2-aril-aminotiazo- les.
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
GB1298577A (en) New stilbene derivatives
ES2107698T3 (es) Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento, como inhibidores del intercambio celular de na+/h+ o como agente de diagnostico, asi como medicamento que las contiene.
ES2139943T3 (es) Nuevos inhibidores de la sintasa de prostaglandina.
ES461388A1 (es) Un procedimiento para la preparacion de un compuesto de pi- rrolidona.
HRP20010117B1 (en) Novel salt form of pantoprazole
HU9301866D0 (en) Benzoxa-condensed-ring-compounds and medical preparatives containing these compounds and processes for production of these compounds and of pharmaceutical composition
ES2137154T3 (es) Boratos bis-(aciloxi-o) del acido (6,7-sustituido-8-alcoxi-1-ciclopropil-1,4-dihidro-4-oxo-3-quinolinocarboxilico-o3,o4 y sus sales, y metodos para su preparacion.
ES433047A1 (es) Un procedimiento para preparar productos intermedios de prostaglandinas.
ES434533A1 (es) Un procedimiento para la preparacion de compuestos tetraci-clicos.
GB2123830A (en) Trisubstituted diazo compounds
ES449096A1 (es) Un procedimiento para la preparacion de 11-desoxi-16-ariloxi-omega-tetranorprostaglandinas.
ES2054502T3 (es) Esteres del acido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0(3.8))-undec-2-en-2-carboxilico y un procedimiento para su preparacion.
ES453632A1 (es) Procedimiento para la obtencion de derivados del acido 4-(a-minoacetil) fenoxiacetico.
JPS5293470A (en) Gelatin curing agent
ES464045A1 (es) Un procedimiento para la produccion de una gamma-pirona.
AR241590A1 (es) Procedimiento para elaborar 1-fenil-3-azabiciclo(3.1.0)hexan-2,4-dionas y sus sales.
GB1497161A (en) Naphthyl derivatives
JPS5227791A (en) Synthesis of cephalosporins
ES478323A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido 2,1-b quinazolina.
ATE191483T1 (de) Trizyklische oximether, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
GB1429039A (en) Dialkylphosphinyl compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981103